Latisse – Read the Patient Reference Leaflet

1
Latisse Read the Patient Reference Leaflet
2
Introduction

• The only product to make it up to the market by
  meeting all desired ends of solving hypotrichosis
  of eyelash problems, Latisse has made a change in
  the aesthetic medical marketplace. Medications
  like
• Latisse are examined under well-controlled
  environments and clinical trials. Its a
  prescription-based product available for
  consumers to purchase.
• Buy Latisse online Usa only when your assigned
  healthcare provider assesses your medical history
  and approves of your tolerance and usage of
  Latisse eyelash solution.
• To learn more visit www.shoptruepills.com

3
Safety Information

• It is designated for use only for the upper
  eyelash margin line and nowhere else on your
  face. Some people do use it for their eyebrows
  which have not been a concrete statement from
  FDA. Hence do not buy generic Latisse online for
  eyebrow usage until recommended.
• If customers are using products similar to
  Latisse, with the same ingredients or products
  belonging to the same class of medications
  controlling IOP, and a history of glaucoma, then
  either stop using Latisse or use it under close
  observation of the doctor.
• This has not been reported post clinical studies
  or trials, but some users have reported darkening
  of eyelid skin. Healthcare experts inform us that
  skin darkening can be reversible.

4
Common After Effects

• The commonly reported side effects are as follows
  
• Itchy feeling in the eyes
• Temporary redness of the eyes
• Constant irritation in the eyes
• Dryness in eyes
• Eyelid redness

5
Contraindications

• People facing hypersensitivity towards the
  Latisse product and its ingredient Bimatoprost
  (0.03). The eyelash product also contraindicates
  people with a history of adverse effects due to
  the usage of Benzalkonium Chloride.
• It can contraindicate in patients below 18 years
  of age hence ensuring that a person under this
  age limit should not use this drug.